You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 2, July 11, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Extract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (64)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Cigarette Smoking as a Risk Factor for Pancreatic Cancer in Patients With Hereditary Pancreatitis

To the Editor: Smoking approximately doubles the risk of pancreatic cancer,1 the fourth most common cause of death from cancer in the United States. In addition, about 5% to 10% of patients have an inherited genetic predisposition to this tumor.2 A large variety of germ-line defects have been detected in families with pancreatic cancer, including the familial pancreatic cancer syndrome, mutations in the BRCA2 gene, the familial atypical multiple mole melanoma syndrome, hereditary nonpolyposis colorectal carcinoma syndrome, the Peutz-Jeghers syndrome, and hereditary pancreatitis.

We previously reported an exceptionally high risk of pancreatic cancer in patients with hereditary pancreatitis, a rare autosomal dominant disorder.3 We now report information on smoking as an additional risk factor in these indviduals.

Methods

By contacting gastroenterologists, pancreatologists, and surgeons, we have established a registry that now includes 497 patients with hereditary pancreatitis. Each respondent has submitted data about demographics, family history, diagnosis, disease course, life-style factors, including smoking and drinking habits, and vital status. The expected number of cancers was determined from available sex, age, and country-specific incidence data.


Results

Of the 497 patient with herditary pancreatitis, 19 biopsy-proven pancreatic cancers were reported, compared with an expected number of 0.33, yielding a risk ratio of 57 (95% confidence interval [CI], 35-90). In this cohort, smoking status was available for 88% of the patients: 40% were either current or former smokers. Of the 19 patients with pancreatic cancer, 11 were current or former smokers, 6 were nonsmokers, and smoking information was missing for 2 patients. As in the general US population, smoking resulted in an approximately 2-fold (age- and sex-adjusted odds ratio [OR], 2.1; 95% CI, 0.7-6.1) increased risk of pancreatic cancer compared with nonsmoking members of the cohort. An unexpected finding was that pancreatic cancer developed 20 years earlier in smokers than in nonsmokers (P = .02). (Figure 1)



View larger version (11K):
[in this window]
[in a new window]
Figure. Age Distribution of Pancreatic Cancer Cases According to Smoking Status

Median age (horizontal lines) at onset of cancer: ever smokers, 50 years and never smokers, 70 years (P = .02, Mann-Whitney test).


Forty-three percent of adults in the cohort had consumed alcohol, and drinking status was known for 17 of the 19 patients with pancreatic cancer. The mean (SD) age of onset of pancreatic cancer in 11 alcohol consumers was 55 (14.7) years, which was nearly identical to the mean age of onset of pancreatic cancer in 6 nonconsumers (56 [17.8] years). In multivariate analysis, a nonsignificant increased risk of pancreatic cancer was observed in consumers vs nonconsumers of alcohol (OR, 2.1; 95% CI, 0.7-6.3).


Comment

Hereditary pancreatitis usually begins in childhood and is now known to be caused by defects in the trypsinogen gene located at 7q35.4 Although the trypsinogen gene is not considered to be a cancer gene, the high risk of pancreatic cancer in these patients may be related to progressive glandular destruction over a long time period.

Our data suggest that in this sample of patients with hereditary pancreatitis, as in the general population, smoking doubles the risk of pancreatic cancer and accounts for approximately 25% to 30% of all pancreatic tumors. In addition, smoking appears to result in a dramatically earlier age of diagnosis of pancreatic cancer, perhaps because of a gene-environment interaction. We believe it is unlikely that either selective overreporting of smoking in young patients or underreporting of smoking in older patients with pancreatic cancer occurred. Evidence has suggested that there is a smoking-genetic interaction in patients with familial pancreatic cancer,5 but additional studies will be required to learn whether smoking has a similar effect in other patients who have an inherited susceptibility to pancreatic cancer. Meanwhile, our data indicate that in this germ-line disorder with a high risk of pancreatic cancer, smoking acts as an independent risk factor and seems to lower the age of onset of this aggressive cancer by approximately 2 decades. In addition, since alcohol can be injurious to the pancreas, we suggest that persons with a predisposition to pancreatic cancer should avoid drinking alcohol.


AUTHOR INFORMATION

Funding/Support: This study was supported by grants from the C.D. Smithers Foundation; Solvay Pharmaceuticals Inc; the Italian Association for Cancer Research; the National Institute of Health (grant DK54709); the German Research Council, and the Interdisciplinary Center for Clinical Research (IZKF), Münster.

Albert B. Lowenfels, MD
Department of Surgery and Community and Preventive Medicine
New York Medical College
Valhalla, NY

Patrick Maisonneuve
Division of Epidemiology and Biostatistics
European Institute of Oncology
Milan, Italy

David C. Whitcomb, MD
Division of Gastroenterology, Hepatology, and Nutrition
Department of Medicine and Center for Genomic Sciences
University of Pittsburgh
Pittsburgh, Pa

Markus M. Lerch, MD
Department of Medicine B
Westfälische Wilhelms Universität
Münster, Germany

Eugene P. DiMagno, MD
Gastroenterology Research Unit
Mayo Clinic
Rochester, Minn

1. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, Runia S, Boyle P. Life-time history of smoking and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer. 1991;49:816-822. ISI | PUBMED
2. Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA. Inherited predisposition to pancreatic cancer. Gut. 2001;48:143-147. FREE FULL TEXT
3. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer: International Hereditary Pancreatitis Study Group. J Natl Cancer Inst. 1997;89:442-446. FREE FULL TEXT
4. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141-145. FULL TEXT | ISI | PUBMED
5. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93:640-644. FREE FULL TEXT

Letters Section Editors: Stephen J. Lurie, MD, PhD, Senior Editor; Jody W. Zylke, MD, Contributing Editor.

JAMA. 2001;286:169-170.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Advances in counselling and surveillance of patients at risk for pancreatic cancer
Brand et al.
Gut 2007;56:1460-1469.
ABSTRACT | FULL TEXT  

Early Onset Pancreatic Cancer: Evidence of a Major Role for Smoking and Genetic Factors
Raimondi et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1894-1897.
ABSTRACT | FULL TEXT  

Role of BRCA1 and BRCA2 mutations in pancreatic cancer
Greer and Whitcomb
Gut 2007;56:601-605.
ABSTRACT | FULL TEXT  

Anticipating disaster: the genetics of familial pancreatic cancer
Lerch
Gut 2006;55:150-151.
FULL TEXT  

Cigarette smoking accelerates progression of alcoholic chronic pancreatitis
Maisonneuve et al.
Gut 2005;54:510-514.
ABSTRACT | FULL TEXT  

Value of genetic testing in the management of pancreatitis
Whitcomb
Gut 2004;53:1710-1717.
FULL TEXT  

Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer
Whitcomb
Am. J. Physiol. Gastrointest. Liver Physiol. 2004;287:G315-G319.
ABSTRACT | FULL TEXT  

Epidemiology and Prevention of Pancreatic Cancer
Lowenfels and Maisonneuve
Jpn J Clin Oncol 2004;34:238-244.
ABSTRACT | FULL TEXT  

Adjuvant therapy in pancreatic cancer: historical and current perspectives
Neoptolemos et al.
Ann Oncol 2003;14:675-692.
ABSTRACT | FULL TEXT  

Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC)
Inoue et al.
Int J Epidemiol 2003;32:257-262.
ABSTRACT | FULL TEXT  

Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis
Howes and Neoptolemos
Gut 2002;51:765-766.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.